Advance Agrolife Limited (NSE: ADVANCE | BSE: 544562)
Source: Advance Agrolife Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026) 📊 Stock Screeners
Advance Agrolife Limited (AAL) is an Indian research-driven agrochemical manufacturer with over two decades of experience in crop protection and crop enhancement solutions. Operating primarily in the business-to-business (B2B) segment, the company manufactures and distributes technical-grade active ingredients and generic/proprietary formulation-grade agrochemicals.
- Technical-Grade Products: High-purity active chemical ingredients synthesized in-house for captive consumption into end-formulations as well as merchant sale to global and domestic formulation manufacturers. Key active chemistries include 2,4-D herbicide technicals and recently commercialized Pretilachlor Technical along with its intermediate PEDA.
- Formulation-Grade Products: Market-ready crop protection formulations processed into varied delivery systems including Emulsifiable Concentrates (EC), Suspension Concentrates (SC), Water Dispersible Granules (WDG), Soluble Liquid (SL), and Wettable Powder (WP) for crop application.
- Crop Enhancement Solutions: Bio-fertilizers containing beneficial soil micro-organisms, plant growth regulators (PGRs) driving flowering and fruit development, and micronutrient fertilizer mixtures addressing trace element deficiencies.
📋 Quick Facts / Company Snapshot: Advance Agrolife Limited (NSE: ADVANCE | BSE: 544562)
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Advance Agrolife Limited |
| Corporate Identity Number (CIN) | L24121RJ2002PLC017467 |
| ISIN | INE1B0W01010 |
| Stock Exchange Listing | BSE Limited (Scrip Code: 544562) | National Stock Exchange of India Limited (Symbol: ADVANCE) |
| Date of Incorporation / Founding Year | February 27, 2002 |
| Registered Office | E-39, RIICO Industrial Area, Bagru (Ext.), Jaipur – 303007, Rajasthan, India |
| Corporate Office | 301, 3rd Floor & 140-B, Pandit TN Mishra Marg, Nirman Nagar, Jaipur – 302019, Rajasthan, India |
| Telephone & Official IR Email | +91-141-4810126 | info@advanceagrolife.com / cs@advanceagrolife.com |
| Chairman & Managing Director | Om Prakash Choudhary (DIN: 01004122) |
| Whole Time Director | Kedar Choudhary (DIN: 06905752) |
| Chief Financial Officer (CFO) | Mewa Ram Mehta |
| Company Secretary & Compliance Officer | Nisha Gupta (Membership No. A42708) |
| Promoter & Holding Group | Om Prakash Choudhary and Kedar Choudhary |
| Industry / Sector Classification | Agrochemicals & Crop Protection Chemicals (Insecticides, Herbicides, Fungicides, PGRs) |
| Total Employees / Workforce | 299 Permanent Employees (as on March 31, 2026) |
| Installed Manufacturing Capacity | 89,900 MTPA across 3 Operational Facilities in Jaipur, Rajasthan |
| Credit Rating & Rating Agency | CARE Ratings Limited: Long-Term Bank Facilities upgraded to CARE BBB+ (Stable); Short-Term Facilities rated CARE A3+ |
| Statutory Auditors | M/s S K Patodia & Associates LLP, Chartered Accountants (FRN: 112723W/W100962) |
| Secretarial Auditors | M/s MSV & Associates, Practicing Company Secretaries (FRN: P2018RJ071900) |
| Cost Auditors | M/s M Goyal & Co., Cost Accountants (Firm Reg No. 000051) |
| Registrar & Share Transfer Agent (RTA) | KFin Technologies Limited (Selenium Tower B, Plot 31-32, Financial District, Nanakramguda, Hyderabad – 500032) |
🏢 The Corporate Identity: Advance Agrolife Overview, Promoters & History
The Big Picture: Business Model & Core Value Proposition
Advance Agrolife Limited (AAL) is an Indian research-driven agrochemical manufacturer with over two decades of experience in crop protection and crop enhancement solutions. Operating primarily in the business-to-business (B2B) segment, the company manufactures and distributes technical-grade active ingredients and generic/proprietary formulation-grade agrochemicals. Its extensive product catalog encompasses insecticides, fungicides, herbicides, plant growth regulators (PGRs), micronutrient fertilizers, and bio-fertilizers designed to boost farm yields, protect crops from pests and fungal diseases, and improve soil health.
The company’s core value proposition revolves around an integrated manufacturing platform built on strategic backward integration. Transitioning from a formulation-heavy supplier to a fully integrated agrochemical manufacturer, Advance Agrolife produces high-value technical active ingredients and key intermediates in-house. This captive production model reduces reliance on third-party suppliers and overseas imports, fortifies supply chain resilience, lowers raw material procurement volatility, and enhances operating margin realization.
Advance Agrolife serves lead players across the B2B agrochemical market while maintaining direct-to-market presence in key agricultural pockets. Supported by an installed production capacity of nearly 89,900 metric tonnes per annum (MTPA) across three strategically designed facilities in Jaipur, Rajasthan, and a product portfolio backed by over 410 product registrations (380+ formulations and 30+ technical registrations), the enterprise delivers custom product solutions and standard bulk supplies across domestic and international agricultural regions.
The Founders, Promoters & Their Legacy
The operational foundation and strategic vision of Advance Agrolife Limited have been shaped by its promoters, Om Prakash Choudhary and Kedar Choudhary, who possess deep industrial and domain experience within the Indian agrochemical and crop protection sectors.
- Om Prakash Choudhary (Chairman & Managing Director): Associated with the organization since November 29, 2005, Om Prakash Choudhary holds a Bachelor of Business Administration and a Master of Business Administration from Rajasthan Technical University. With over 24 years of hands-on experience in the agrochemical sector, he leads the enterprise’s strategic trajectory, overseeing portfolio expansion, capital allocation, technology adoption, regulatory filings, and long-term business development.
- Kedar Choudhary (Whole Time Director): Serving on the Board of Directors since January 25, 2016, Kedar Choudhary holds a Bachelor of Computer Applications from the University of Rajasthan, Jaipur. Bringing over a decade of industry expertise, he oversees plant operations, administrative infrastructure, supply chain execution, financial management, and international market expansion.
- Narendra Choudhary (Executive Director): Associated with the company since October 1, 2020, and appointed to the Board on November 30, 2023, Narendra Choudhary holds a Bachelor of Commerce and a Master of Commerce from the University of Rajasthan. He supervises manufacturing management, budgeting, financial planning, regulatory compliance, and plant operational efficiency.
The Journey: Corporate History & Key Milestones
Incorporated on February 27, 2002, as Advance Agrolife Private Limited, the company began as a small-scale agrochemical blending unit in Jaipur, Rajasthan, initially focusing on micro-nutrient fertilizer mixtures. Over the subsequent two decades, the enterprise progressively expanded its asset base, widened its chemistry capabilities, built testing laboratories, and secured a broad array of formulation registrations under the Central Insecticides Board and Registration Committee (CIBRC) regulatory framework.
In FY 2024-25, the company underwent a structural corporate transformation. Following a special resolution passed at its Extra-Ordinary General Meeting on November 13, 2024, the enterprise converted from a private limited entity into a public limited company, receiving a fresh Certificate of Incorporation dated December 4, 2024, as Advance Agrolife Limited.
FY 2025-26 marked a watershed operational and financial year for Advance Agrolife Limited, defined by its successful capital market transition, significant backward integration progress, asset expansion, and credit profile enhancement:
- Initial Public Offering (IPO) & Mainboard Listing: In October 2025, the company completed a 100% fresh issue IPO of 1,92,85,720 equity shares at ₹100 per share (including ₹90 premium), raising ₹192.84 Crores. The issue witnessed robust demand, being subscribed 56.90 times overall, and listed on the BSE and NSE on October 08, 2025.
- Backward Integration Milestone: The company successfully commenced commercial production of Pretilachlor Technical and its core intermediate PEDA (2,6-Diethyl-N-(2-propoxyethyl) Aniline) at its Unit-I manufacturing hub, establishing backward integration for paddy weed control solutions.
- Asset & Footprint Expansion: Advanced development work on Unit IV at Gidhani, Jaipur (technical manufacturing plant), after securing Terms of Reference (ToR) approval from the Ministry of Environment, Forest and Climate Change (MoEFCC). Simultaneously, signed an MoU for acquiring 17,734.54 sq mtrs of land at Dahej II GIDC Industrial Estate, Bharuch, Gujarat, for a proposed technical plant (Unit V).
- Green Energy Transition: Initiated the establishment of a 3.75 MW captive solar power project at Jodhpur, Rajasthan, to expand renewable energy usage and lower operating power costs.
- Credit Rating Upgrade: CARE Ratings Limited upgraded the company’s long-term bank facilities rating from CARE BBB (Stable) to CARE BBB+ (Stable) and assigned CARE A3+ for short-term facilities.
The Corporate Umbrella & Group Structure
Advance Agrolife Limited operates as a standalone operating entity without any subsidiary companies, joint ventures, or associate entities as of March 31, 2026. The enterprise carries out all technical synthesis, formulation processing, quality control testing, and commercial activities under its standalone corporate balance sheet.
⚙️ The Business Engine: Advance Agrolife Segments, Brands, Products & Operations
The Core Divisions & Segment Revenue Breakdown
Advance Agrolife operates strictly under a single reportable operating business segment as per Ind AS 108 (“Agrochemicals / Pesticides Products”). However, internal management performance systems track revenue across key chemistry classifications: Herbicides, Fungicides, Insecticides, Technical-Grade Actives, Plant Growth Regulators (PGRs), Micronutrient Fertilizers, and others.
| Product / Revenue Classification | FY 2025-26 Revenue (₹ in Crores) | % Share of Total Revenue | FY 2024-25 Revenue (₹ in Crores) | % Share of Total Revenue | Latest YoY (%) |
|---|---|---|---|---|---|
| Herbicides | 260.40 | 40.83% | 200.90 | 40.00% | +29.62% |
| Fungicides | 168.37 | 26.40% | 130.59 | 26.00% | +28.93% |
| Insecticides | 156.64 | 24.56% | 125.57 | 25.00% | +24.74% |
| Technical-Grade Active Ingredients | 39.92 | 6.26% | 32.65 | 6.50% | +22.27% |
| Plant Growth Regulators (PGRs) | 0.83 | 0.13% | 1.00 | 0.20% | -17.00% |
| Fertilizers (Micronutrients & Bio-fertilizers) | 2.68 | 0.42% | 2.51 | 0.50% | +6.77% |
| Others (Services & Scrap) | 8.93 | 1.40% | 9.04 | 1.80% | -1.22% |
| Total Revenue from Operations | 637.78 | 100.00% | 502.26 | 100.00% | +26.98% |
In terms of product grade mix, Formulation-Grade Agrochemicals accounted for 92.34% of net revenues in FY 2025-26, while Technical-Grade products contributed 6.26%, and other specialty inputs contributed 1.40%.
The Product & Service Catalog
The company maintains a product library supported by over 410 product registrations approved by the CIBRC regulatory framework. Its core offerings are structured across two major product classes:
- Technical-Grade Products: High-purity active chemical ingredients synthesized in-house for captive consumption into end-formulations as well as merchant sale to global and domestic formulation manufacturers. Key active chemistries include 2,4-D herbicide technicals and recently commercialized Pretilachlor Technical along with its intermediate PEDA.
- Formulation-Grade Products: Market-ready crop protection formulations processed into varied delivery systems including Emulsifiable Concentrates (EC), Suspension Concentrates (SC), Water Dispersible Granules (WDG), Soluble Liquid (SL), and Wettable Powder (WP) for crop application.
- Crop Enhancement Solutions: Bio-fertilizers containing beneficial soil micro-organisms, plant growth regulators (PGRs) driving flowering and fruit development, and micronutrient fertilizer mixtures addressing trace element deficiencies.
Under Ind AS 108 disclosures, Advance Agrolife monitors customer concentration. In FY 2025-26, sales to major key B2B customers were as follows:
- Customer 1: ₹67.49 Crores (10.58% of total revenue) vs. ₹0.50 Crores in FY 2024-25.
- Customer 2: ₹58.04 Crores (9.10% of total revenue) vs. ₹87.98 Crores in FY 2024-25.
- Customer 3: ₹55.22 Crores (8.66% of total revenue) vs. ₹0.48 Crores in FY 2024-25.
- Aggregate Top Customer Concentration: The three largest customers collectively accounted for ₹180.75 Crores, representing 28.34% of total turnover in FY 2025-26.
The Names You Know: Key Brands & Flagship Portfolio
Advance Agrolife markets its technical and formulation products via proprietary, in-licensed, and private-label B2B channel arrangements. The table below highlights key functional categories across its crop protection suite:
| Brand / Product Line | Category / Business Segment | Target Market & Key Positioning |
|---|---|---|
| Pretilachlor Technical & PEDA | Technical Active & Intermediate | Paddy weed control chemistry; integrated captive consumption and B2B merchant sale. |
| 2,4-D Herbicide Series | Herbicides / Technical & Formulations | Broad-spectrum weed control in sugarcane, wheat, and maize crops. |
| Sulphur Specialty Formulations | Fungicides & Crop Nutrition | High-density dust free WDG/WP sulphur formulations for powdery mildew and soil nutrient correction. |
| Bio-Fertilizer & PGR Range | Crop Enhancement Solutions | Yield-enhancing micro-organisms and PGRs promoting root development, flowering, and stress tolerance. |
Mapping the Domestic & Global Reach (India vs. Exports)
Advance Agrolife maintains a physical footprint covering 19 Indian States and 2 Union Territories, alongside an export network expanding across 7 countries globally (including Türkiye, Egypt, Kenya, UAE, China, Bangladesh, and Nepal).
| Geographic Region | FY 2025-26 Revenue (₹ in Crores) | % Share of Total Revenue | FY 2024-25 Revenue (₹ in Crores) | % Share of Total Revenue | Latest YoY (%) |
|---|---|---|---|---|---|
| Domestic (India) | 622.64 | 97.63% | 492.11 | 97.98% | +26.52% |
| International (Exports) | 15.14* | 2.37% | 10.15* | 2.02% | +49.16% |
| Total Sales Revenue | 637.78 | 100.00% | 502.26 | 100.00% | +26.98% |
*Note: Export sales revenue includes direct export product sales of ₹14.85 Crores and export duty incentives of ₹0.28 Crores in FY 2025-26 (compared to ₹9.81 Crores export sales and ₹0.34 Crores incentives in FY 2024-25).
The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices
The company operates an integrated manufacturing base with a total installed capacity of 89,900 MTPA spanning 49,543 sq.m. of land across three operational production centers in Jaipur, Rajasthan, supported by upcoming expansion projects:
- Unit I (The Technical Hub – Bagru, Jaipur, Rajasthan): Installed Capacity of 6,900 MT. Focuses on synthesizing Technical-Grade active ingredients (including 2,4-D and Pretilachlor Technical / PEDA), driving backward integration and supply chain independence.
- Unit II (The Sulphur Specialty Facility – Dahami Khurd, Jaipur, Rajasthan): Installed Capacity of 51,000 MT. High-margin niche plant focused on sulphur-based crop protection and nutritional formulations; represents one of the largest single-location sulphur processing setups globally.
- Unit III (The Volume Manufacturing Engine – Dhami Khurd, Jaipur, Rajasthan): Installed Capacity of 32,000 MT. High-volume formulation plant processing insecticides, herbicides, and bio-fertilizers for large-scale B2B supply.
- Unit IV (Technical Expansion – Gidhani, Jaipur, Rajasthan): Under active project execution on acquired land (Khasra No. 2408/1654 and 2409/1654). Designed as an advanced technical-grade synthesis plant to expand backward integration. ToR approval received from MoEFCC; commissioning targeted for Q3-2027.
- Unit V (Proposed Facility – Dahej, Gujarat): MoU signed to acquire 17,734.54 sq mtrs of land at Dahej II GIDC Industrial Estate, Bharuch, Gujarat, dedicated to technical-grade pesticide manufacturing.
- R&D & Quality Control Hubs: In-house testing laboratory infrastructure deployed across operational plants for raw material validation and product batch testing. The company proposes to build a state-of-the-art NABL-accredited R&D Center to accelerate formulation innovation and international registration filings.
📊 The Financial Health: Advance Agrolife Financial Statements & Numbers Simplified
Multi-Year Financial Highlights
The table below summarizes key financial trends of Advance Agrolife Limited over the past three fiscal years (FY 2023-24 to FY 2025-26):
| Financial Indicator | FY 2025-26 (₹ in Crores) | FY 2024-25 (₹ in Crores) | FY 2023-24 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|---|
| Revenue from Operations | 637.78 | 502.26 | 455.90 | +26.98% |
| EBITDA | 63.69 | 48.25 | 40.21 | +32.00% |
| Profit Before Tax (PBT) | 48.11 | 35.20 | 33.29 | +36.68% |
| Profit After Tax (PAT) | 35.28 | 25.64 | 24.73 | +37.60% |
| Total Equity / Net Worth | 309.92 | 100.87 | 70.76 | +207.25% |
| Total Debt (Borrowings + Leases) | 97.89 | 80.45 | 45.45 | +21.68% |
| EBITDA Margin (%) | 10.61% | 9.61% | 8.82% | – |
| PAT Margin (%) | 5.53% | 5.10% | 5.42% | – |
| Return on Net Worth / ROE (%) | 11.38% | 25.42% | 39.30% | – |
| Return on Capital Employed / ROCE (%) | 17.24% | 34.87% | 37.62% | – |
Earnings, Expenses, & Take-Home Profits (Statement of Profit & Loss)
In FY 2025-26, Advance Agrolife Limited recorded Revenue from Operations of ₹637.78 Crores, representing a growth of 26.98% YoY compared to ₹502.26 Crores in FY 2024-25. Operating expansion was driven by robust volume demand across core herbicides and fungicides, along with deeper customer coverage across domestic state markets.
| Statement of Profit and Loss Line Item | FY 2025-26 (₹ in Crores) | FY 2024-25 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| Revenue from Operations | 637.78 | 502.26 | +26.98% |
| Other Income | 3.98 | 0.62 | +541.94% |
| Total Income | 641.75 | 502.88 | +27.61% |
| Cost of Materials Consumed | 508.32 | 380.63 | +33.55% |
| Change in Inventories of Finished Goods & WIP | (20.42) | 1.50 | N/M |
| Manufacturing & Operating Expenses | 41.49 | 31.83 | +30.35% |
| Employee Benefits Expense | 15.04 | 11.31 | +32.98% |
| EBITDA (Disclosed / Computed) | 63.69 | 48.25 | +32.00% |
| Depreciation and Amortisation Expenses | 10.88 | 7.61 | +42.97% |
| Operating Profit (EBIT) | 56.78 | 40.63 | +39.75% |
| Finance Costs | 8.67 | 5.43 | +59.67% |
| Other Expenses | 29.66 | 29.37 | +0.99% |
| Total Expenses | 593.64 | 467.68 | +26.93% |
| Profit Before Tax (PBT) | 48.11 | 35.20 | +36.68% |
| Current Tax Expense | 12.51 | 9.74 | +28.44% |
| Deferred Tax Expense / (Credit) | 0.31 | (0.18) | N/M |
| Total Tax Expense | 12.83 | 9.56 | +34.21% |
| Profit After Tax (PAT) / Net Profit | 35.28 | 25.64 | +37.60% |
| Other Comprehensive Income (Net of Tax) | (0.05) | (0.03) | +66.67% |
| Total Comprehensive Income | 35.23 | 25.61 | +37.56% |
Assets, Borrowings, & Net Worth (Balance Sheet)
As of March 31, 2026, the company’s Balance Sheet expanded significantly to ₹624.99 Crores compared to ₹351.47 Crores in FY 2024-25. This strengthening was anchored by the successful equity capital raise via the Initial Public Offering, which elevated Total Equity from ₹100.87 Crores to ₹309.92 Crores.
| Balance Sheet Line Item | As at March 31, 2026 (₹ in Crores) | As at March 31, 2025 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| ASSETS | |||
| 1. Non-Current Assets | |||
| Property, Plant and Equipment | 81.04 | 64.72 | +25.22% |
| Capital Work-In-Progress (CWIP) | 22.22 | 10.55 | +110.62% |
| Right-of-Use Assets | 1.66 | 1.16 | +43.10% |
| Other Intangible Assets | 0.20 | 0.00 | N/M |
| Intangible Assets under Development | 0.00 | 0.45 | -100.00% |
| Non-Current Financial Assets – Others | 1.92 | 0.67 | +186.57% |
| Deferred Tax Assets (Net) | 0.47 | 0.76 | -38.16% |
| Other Non-Current Assets (Capital Advances) | 23.11 | 0.70 | +3201.43% |
| Total Non-Current Assets | 130.62 | 79.01 | +65.32% |
| 2. Current Assets | |||
| Inventories | 205.22 | 87.61 | +134.24% |
| Trade Receivables | 196.24 | 163.07 | +20.34% |
| Cash and Cash Equivalents | 5.45 | 0.58 | +839.66% |
| Bank Balances Other than Cash & Cash Equivalents | 69.67 | 1.34 | +5099.25% |
| Other Current Financial Assets | 1.86 | 0.15 | +1140.00% |
| Other Current Assets | 15.92 | 19.71 | -19.23% |
| Total Current Assets | 494.37 | 272.46 | +81.45% |
| TOTAL ASSETS | 624.99 | 351.47 | +77.82% |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Equity Share Capital | 64.29 | 45.00 | +42.87% |
| Other Equity | 245.63 | 55.87 | +339.65% |
| Total Equity (Net Worth) | 309.92 | 100.87 | +207.25% |
| Liabilities | |||
| 1. Non-Current Liabilities | |||
| Non-Current Borrowings (Term Loans) | 17.36 | 14.79 | +17.38% |
| Non-Current Lease Liabilities | 1.26 | 0.23 | +447.83% |
| Non-Current Provisions (Gratuity) | 0.82 | 0.63 | +30.16% |
| Total Non-Current Liabilities | 19.43 | 15.64 | +24.23% |
| 2. Current Liabilities | |||
| Current Borrowings (Working Capital Loans + Current Term Debt) | 78.70 | 64.46 | +22.09% |
| Current Lease Liabilities | 0.58 | 0.98 | -40.82% |
| Trade Payables – MSME Dues | 4.89 | 5.19 | -5.78% |
| Trade Payables – Other Creditors | 204.18 | 153.57 | +32.96% |
| Other Current Financial Liabilities | 1.34 | 1.03 | +30.10% |
| Other Current Liabilities (Statutory & Advances) | 1.36 | 0.38 | +257.89% |
| Current Provisions | 0.84 | 0.19 | +342.11% |
| Current Tax Liabilities (Net) | 3.74 | 9.17 | -59.21% |
| Total Current Liabilities | 295.64 | 234.96 | +25.83% |
| Total Liabilities (Excluding Equity) | 315.07 | 250.60 | +25.73% |
| TOTAL EQUITY AND LIABILITIES | 624.99 | 351.47 | +77.82% |
Working Capital Cycle & Schedule III Statutory Ratio Explanations
Advance Agrolife’s working capital footprint underwent structural adjustments during FY 2025-26 as fresh equity proceeds from the IPO expanded current liquid assets and bank balances while inventory buffers were built up to support higher plant throughput.
| Statutory Key Financial Ratio | FY 2025-26 | FY 2024-25 | Management Explanation for Variance >25% | Latest YoY (%) |
|---|---|---|---|---|
| Current Ratio | 1.67x | 1.16x | Improved due to strengthening of working capital and liquidity following IPO proceeds infusion. | +43.97% |
| Debt-Equity Ratio | 0.32x | 0.80x | Improved significantly due to expansion of Net Worth following IPO equity capital infusion. | -60.00% |
| Inventory Turnover Ratio | 3.33x | 5.60x | Decreased due to higher raw material & finished goods inventory built to support enlarged capacity. | -40.54% |
| Return on Net Worth (ROE) | 11.38% | 25.42% | Moderated as average Net Worth grew proportionately higher than PAT growth post-IPO capital raise. | – |
| Net Capital Turnover Ratio | 3.21x | 13.39x | Decreased due to a significant rise in net working capital assets following IPO fund deployment. | -76.03% |
| Return on Capital Employed (ROCE) | 17.24% | 34.87% | Moderated due to higher average capital base following the public equity issue. | – |
| Trade Receivables Turnover | 3.55x | 3.28x | Operational variance within normal trading range. | +8.23% |
| Trade Payables Turnover | 3.18x | 2.94x | Operational variance within normal trading range. | +8.16% |
| Interest Coverage Ratio | 6.55x | 7.48x | Operational variance within normal trading range. | -12.43% |
| Operating Profit Margin (%) | 8.28% | 7.97% | Operational variance within normal trading range. | – |
| Net Profit Margin (%) | 35.28 | 5.10% | Operational variance within normal trading range. | – |
Cash Flow: Tracking the Money Movement
The Statement of Cash Flows highlights capital flows associated with the initial public offering, capital expenditure investments, working capital build-up, and debt servicing during FY 2025-26:
| Cash Flow Statement Line Item | FY 2025-26 (₹ in Crores) | FY 2024-25 (₹ in Crores) | Latest YoY (%) |
|---|---|---|---|
| Operating Profit Before Working Capital Changes | 66.63 | 47.94 | +38.99% |
| (Increase) / Decrease in Inventories | (117.62) | (38.71) | +203.85% |
| (Increase) / Decrease in Trade Receivables | (33.17) | (19.92) | +66.52% |
| Increase / (Decrease) in Trade Payables | 50.32 | 31.70 | +58.74% |
| Other Working Capital Movements (Net) | (18.25) | (7.72) | +136.40% |
| Direct Income Taxes Paid (Net) | (17.94) | (7.58) | +136.68% |
| Net Cash (Used in) / Generated from Operating Activities | (70.04) | 5.71 | N/M |
| Purchase of PPE & CWIP (CapEx Payments) | 0.39 | 0.33 | +18.18% |
| Purchase of Intangible Assets & Development | (0.08) | (0.46) | -82.61% |
| Investment in Bank Fixed Deposits (Net) | (69.58) | (0.57) | +12107.02% |
| Interest Received & Asset Sales | 1.12 | 0.31 | +261.29% |
| Net Cash (Used in) / Generated from Investing Activities | (107.67) | (33.87) | +217.89% |
| Proceeds from Issue of Share Capital (IPO Fresh Issue) | 19.29 | 0.00 | N/M |
| Securities Premium Received from IPO | 154.52 | 0.00 | N/M |
| Net Increase / (Decrease) in Long-Term Borrowings | 2.57 | 0.87 | +195.40% |
| Net Increase / (Decrease) in Short-Term Borrowings | 14.24 | 32.99 | -56.84% |
| Finance Costs & Lease Payments Paid | (8.04) | (5.58) | +44.09% |
| Net Cash Generated from Financing Activities | 182.58 | 28.28 | +545.62% |
| Net Increase / (Decrease) in Cash & Cash Equivalents | 4.88 | 1.19 | +310.08% |
| Cash & Cash Equivalents at Beginning of Year | 0.58 | 0.46 | +26.09% |
| Cash & Cash Equivalents at End of Year | 5.45 | 0.58 | +839.66% |
Funding the Future: CapEx, CWIP, R&D Intensity & Net Foreign Exchange
Capital deployment during FY 2025-26 focused on expanding production infrastructure and technology capabilities:
- Property, Plant & Equipment Additions: Incurred gross CapEx additions of ₹26.52 Crores on property, plant, and machinery equipment in FY 2025-26 (compared to ₹32.01 Crores in FY 2024-25). Capital Work-in-Progress (CWIP) stood at ₹22.22 Crores as of March 31, 2026, primarily reflecting building construction (₹11.47 Crores) and plant equipment erection (₹10.75 Crores) for Unit IV. Capital advances for upcoming projects stood at ₹23.11 Crores.
- Research & Development Expenditure: Operating R&D expenditure incurred during FY 2025-26 was ₹0.19 Crores vs. ₹0.37 Crores in FY 2024-25, focused on developing generic and proprietary formulation chemistry combinations and regulatory data generation.
- Foreign Exchange Earnings & Outgo (Section 134(3)(m)):
- Total Foreign Exchange Earned (Exports): ₹14.85 Crores (₹14,85,42,117) in FY 2025-26.
- Total Foreign Exchange Used (Imports / Expenses): ₹71.71 Crores (₹71,71,21,702) in FY 2025-26, driven primarily by raw material import purchases of technical ingredients and intermediates.
👥 Power & Control: Advance Agrolife Governance, Leadership & Shareholding Pattern
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
Advance Agrolife’s Board of Directors consists of 6 directors, comprising an equal 50:50 combination of Executive Directors and Non-Executive Independent Directors (including two women Independent Directors):
| Name of Director / KMP | Designation / Role | DIN / Membership | Board Category |
|---|---|---|---|
| Om Prakash Choudhary | Chairman & Managing Director | DIN: 01004122 | Executive Promoter Director |
| Kedar Choudhary | Whole Time Director | DIN: 06905752 | Executive Promoter Director |
| Narendra Choudhary | Executive Director (Re-designated Whole Time Director) | DIN: 10410584 | Executive Professional Director |
| Rakesh Verma | Independent Director | DIN: 02242428 | Non-Executive Independent (Woman) |
| Seema Singh | Independent Director | DIN: 10042852 | Non-Executive Independent (Woman) |
| Manjit Singh Kochar | Independent Director | DIN: 08298764 | Non-Executive Independent Director |
| Mewa Ram Mehta | Chief Financial Officer (CFO) | KMP Key Executive | Key Managerial Personnel |
| Nisha Gupta | Company Secretary & Compliance Officer | ACS-42708 | Key Managerial Personnel |
Note: The Board of Directors has proposed the appointment of Mr. Brij Mohan Sharma (DIN: 09646943), former Executive Director of Canara Bank, as an Additional Non-Executive Independent Director for a 5-year term starting August 06, 2026, subject to shareholder approval at the 24th AGM.
Who Owns the Stock? Shareholding Pattern
Following the allotment of 1,92,85,720 equity shares under the initial public offer on October 06, 2025, the paid-up equity capital expanded to ₹64.29 Crores (comprising 6,42,85,720 equity shares of face value ₹10 each). The shareholding structure as of March 31, 2026, is detailed below:
| Shareholder Category | Number of Equity Shares Held | % of Total Issued Shares |
|---|---|---|
| Promoter & Promoter Group | 4,49,30,000 | 69.89% |
| Om Prakash Choudhary | 2,43,76,380 | 37.92% |
| Kedar Choudhary | 1,62,23,220 | 25.24% |
| Other Promoter Group Entities | 43,30,400 | 6.73% |
| Institutional Investors | 28,91,871 | 4.50% |
| Foreign Portfolio Investors (FPIs) | 16,58,476 | 2.58% |
| Alternative Investment Funds (AIFs) | 12,13,395 | 1.89% |
| Qualified Institutional Buyers (QIBs) | 20,000 | 0.03% |
| Public / Non-Institutional Shareholders | 1,64,63,849 | 25.61% |
| Total Issued Equity Shares | 6,42,85,720 | 100.00% |
🗺️ The Corporate Family Tree: Group Structure, Ratings & Contingent Liabilities
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
Advance Agrolife Limited has no subsidiaries, associate entities, or joint venture companies. Consequently, reporting under Form AOC-1 is not applicable.
Strategic Investments, Credit Ratings, Banking Consortium & Contingent Liabilities
The enterprise’s liquidity position, banking infrastructure, credit ratings, and off-balance-sheet commitments as of March 31, 2026, include:
- Credit Ratings (CARE Ratings Limited):
- Long-Term Bank Facilities (₹100.89 Crores): Upgraded to CARE BBB+; Stable (from CARE BBB; Stable).
- Long-Term / Short-Term Facilities (₹6.00 Crores): Assigned CARE BBB+; Stable / CARE A3+.
- Short-Term Bank Facilities (₹6.20 Crores): Reaffirmed/Assigned CARE A3+.
- Banking Consortium & Credit Limits: Banking relationships are anchored by Punjab National Bank (MCC-1, Jaipur). Credit facilities include working capital limits (Cash Credit of ₹70.00 Crores, Packing Credit sub-limit of ₹0.50 Crores, Foreign Usage Bill Purchase sub-limit of ₹0.50 Crores, Ad-hoc limits of ₹0.75 Crores, and Non-Fund based limits of ₹17.20 Crores) secured by primary hypothecation of current assets and collateral charges on manufacturing land & building assets across Units I, II, III, and Unit IV (Gidhani).
- Off-Balance Sheet Contingent Liabilities & Commitments:
- GST Tax Matters: Disputed Goods and Services Tax (GST) demands under appeal totaling ₹0.27 Crores. The management, based on legal advice, considers the claim non-tenable.
- CSR Statutory Non-Compliance Potential Liability: The company recorded unspent CSR obligations across historical years (FY 2020-21: ₹0.10 Cr, FY 2021-22: ₹0.18 Cr, FY 2022-23: ₹0.23 Cr, FY 2023-24: ₹0.12 Cr). Section 135(7) of the Companies Act provides for penalties up to twice the unspent amount or ₹1.00 Crore, resulting in a maximum potential penalty exposure of ₹1.26 Crores. All cumulative unspent amounts up to FY 2024-25 were fully deposited into statutory funds by January 13, 2025.
🎯 The Strategic Outlook: Competitive Moats, Risks, Growth Plans & FAQs
Competitive Advantages & Economic Moats
Advance Agrolife’s operational resilience and sector positioning are underpinned by distinct competitive moats:
- Integrated Backward Integration Model: Captive synthesis of active technicals (such as 2,4-D and Pretilachlor Technical / PEDA) shields operating margins from global raw material price swings and supply chain bottlenecks, providing cost competitiveness over formulation-only peers.
- Extensive Regulatory Asset Portfolio: Holding over 410 product registrations (380+ formulations and 30+ technical active ingredients) with the CIBRC creates a defensible regulatory entry barrier, enabling rapid product roll-outs across domestic state markets.
- Large-Scale Manufacturing Asset Base: Installed manufacturing capacity of 89,900 MTPA across three specialized plants in Jaipur delivers economies of scale, operational flexibility, and volume execution for major B2B agrochemical brands.
- Diversified Product Portfolio: Broad product coverage spanning herbicides (40.83%), fungicides (26.40%), insecticides (24.56%), technicals (6.26%), and crop nutrients mitigates segment-specific crop failure and seasonal demand risks.
What Could Go Wrong? Key Challenges & Business Risks
Management actively monitors key operational and external risk factors:
- Climatic & Monsoon Volatility: Domestic crop protection demand remains closely tied to seasonal rainfall patterns, monsoon distribution, and sowing cycles across India’s Kharif and Rabi seasons.
- Global Technical Oversupply & Pricing Pressures: Price undercut risks and aggressive dumping of technical-grade active ingredients by Chinese chemical exporters can compress realization margins on legacy formulation products.
- Raw Material Import Dependence & FX Volatility: The company incurred foreign exchange outgo of ₹71.71 Crores in FY 2025-26 primarily for raw material active imports, exposing cost structures to currency exchange fluctuations.
- Strict Regulatory Environment: Stringent environmental standards and lengthy registration approval timelines for new chemical molecules can delay commercial launch schedules and escalate compliance costs.
The Next Chapter: Growth, Order Pipeline & CapEx Initiatives
Advance Agrolife’s medium-term strategic roadmap focuses on accelerating technical capacity expansion, deepening supply chain integration, and extending global market penetration:
- Commissioning Unit IV Technical Facility: Advancing construction of the greenfield Unit IV technical-grade active manufacturing facility at Gidhani, Jaipur, targeted for commissioning in Q3-2027 to boost internal backward integration ratios and merchant technical sales.
- Establishing Unit V at Dahej, Gujarat: Executing land acquisition and preliminary engineering for the proposed Unit V facility at the Dahej II GIDC Industrial Estate, placing the enterprise in India’s leading chemical hub to tap global export markets.
- Captive Renewable Energy Integration: Completing the installation of the 3.75 MW solar power project at Jodhpur, Rajasthan, to lower power expenses across its manufacturing plants.
- Expanding Overseas Regulatory Registrations: Pursuing technical active and formulation product registrations across high-value international geographies, including Europe, Latin America, and Southeast Asia, to scale export revenue contributions.
The Verdict: Strategic Outlook & Conclusion
FY 2025-26 represented a defining operational milestone for Advance Agrolife Limited. By executing a mainboard Initial Public Offering that raised ₹192.84 Crores, the enterprise strengthened its equity capital base, reduced financial leverage (lowering its Debt-to-Equity ratio to 0.32x), and expanded total net worth to ₹309.92 Crores. With revenues expanding 27% to ₹637.78 Crores and Net Profit rising 38% to ₹35.28 Crores, the company’s focus on backward integration—demonstrated by the commercial production of Pretilachlor Technical and PEDA—positions it to capture market share across India’s evolving crop protection sector.
Frequently Asked Questions (FAQs) About Advance Agrolife
Q1: What does Advance Agrolife Limited manufacture and what are its key products?
Advance Agrolife Limited manufactures technical-grade active chemical ingredients and formulation-grade crop protection chemicals, including insecticides, herbicides, fungicides, plant growth regulators (PGRs), micronutrient fertilizers, and bio-fertilizers. Key products include 2,4-D herbicides, Pretilachlor Technical & PEDA intermediate, and sulphur-based specialty formulations.
Q2: What were Advance Agrolife’s revenue and net profit figures in FY 2025-26?
In FY 2025-26, Advance Agrolife Limited reported Revenue from Operations of ₹637.78 Crores (up 26.98% YoY from ₹502.26 Crores in FY 2024-25), EBITDA of ₹63.69 Crores, and Net Profit After Tax (PAT) of ₹35.28 Crores (up 37.60% YoY from ₹25.64 Crores in FY 2024-25).
Q3: Who are the promoters and Managing Director of Advance Agrolife Limited?
The company is promoted by Om Prakash Choudhary (Chairman & Managing Director) and Kedar Choudhary (Whole Time Director), who collectively hold 63.15% direct equity shareholding (and control 69.89% total promoter group shareholding) as of March 31, 2026.
Q4: Where are Advance Agrolife’s manufacturing facilities located?
Advance Agrolife operates three production facilities in Jaipur, Rajasthan (Unit I at Bagru, Unit II and Unit III at Dahami Khurd) with a total installed capacity of 89,900 MTPA. It is currently developing Unit IV at Gidhani, Jaipur, and has signed an MoU for land acquisition for Unit V at Dahej, Gujarat.
Q5: What is Advance Agrolife’s debt profile, credit rating, and net worth?
As of March 31, 2026, Advance Agrolife Limited held Total Equity (Net Worth) of ₹309.92 Crores, Non-Current Borrowings of ₹17.36 Crores, and Current Borrowings of ₹0.79 Crores. Its long-term bank loan facilities are rated CARE BBB+ (Stable) by CARE Ratings Limited.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.advanceagrolife.com